Contrast between innovator drug- and generic drug-induced renal dysfunction on coronary angiography (CONTRAST study).

MLA

Nakamura, Ayumi, et al. “Contrast between Innovator Drug- and Generic Drug-Induced Renal Dysfunction on Coronary Angiography (CONTRAST Study).” Heart and Vessels, vol. 29, no. 5, Sept. 2014, pp. 603–10. EBSCOhost, https://doi.org/10.1007/s00380-013-0410-6.

APA

Nakamura, A., Miura, S.-I., Sugihara, M., Miyase, Y., Norimatsu, K., Shiga, Y., Nishikawa, H., & Saku, K. (2014). Contrast between innovator drug- and generic drug-induced renal dysfunction on coronary angiography (CONTRAST study). Heart and Vessels, 29(5), 603–610. https://doi.org/10.1007/s00380-013-0410-6

Chicago

Nakamura, Ayumi, Shin-Ichiro Miura, Makoto Sugihara, Yuiko Miyase, Kenji Norimatsu, Yuhei Shiga, Hiroaki Nishikawa, and Keijiro Saku. 2014. “Contrast between Innovator Drug- and Generic Drug-Induced Renal Dysfunction on Coronary Angiography (CONTRAST Study).” Heart and Vessels 29 (5): 603–10. doi:10.1007/s00380-013-0410-6.